SCHEMBL1449519

SCHEMBL1449519

Nc1ccc(Oc2ccc(CCO)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ TSHR P16473 1/20 0.58
▸ GFER P55789 2/20 0.52
▸ MAOA P21397 3/20 0.50
▸ MAPT P10636 3/20 0.48
▸ MAOB P27338 2/20 0.48
▸ TEAD4 Q15561 1/20 0.48
▸ PARP10 Q53GL7 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ NLRP1 Q9C000 1/20 0.47
▸ NOD2 Q9HC29 1/20 0.47
▸ CA2 P00918 1/20 0.46
▸ LTA4H P09960 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2167811 0.89 CA2 (0.56) ALDH1A1TDP1TSHRMAPTMEN1
SCHEMBL12110749 0.87 ALDH1A1 (0.70) ALDH1A1TDP1CYP3A4TSHRGFER
SCHEMBL309841 0.87 ALDH1A1 (0.70) ALDH1A1TDP1CYP3A4TSHRGFER
SCHEMBL6051 0.87 GFER (0.68) ALDH1A1TDP1CYP3A4TSHRGFER
Ethylene Glycol SCHEMBL19307699 0.84 ALDH1A1 (0.74) ALDH1A1TDP1CYP3A4TSHRGFER
SCHEMBL23748641 0.83 LTA4H (0.65) ALDH1A1TDP1CYP3A4TSHRGFER
SCHEMBL712164 0.83 ALDH1A1 (0.64) ALDH1A1TDP1CYP3A4TSHRGFER
SCHEMBL12110748 0.83 ALDH1A1 (0.64) ALDH1A1TDP1CYP3A4TSHRGFER
SCHEMBL1857603 0.83 ALDH1A1 (0.64) ALDH1A1TDP1CYP3A4TSHRGFER
SCHEMBL1049649 0.83 ALDH1A1 (0.64) ALDH1A1TDP1CYP3A4TSHRGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385040-A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient ONO Pharmaceutical Co., Ltd. (JP) 2011-11-09 — — EP disclosed
US-7910741-B2 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2011-03-22 — — US disclosed
US-20060178399-A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2006-08-10 — — US disclosed
EP-1604981-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2005-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178399-A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient HLA-DRB1, ELANE, MMP8 ALDH1A1 1160/4885TDP1 4035/4885CYP3A4 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback